Bio-Path Holdings, Inc.

Organization

Bellaire, TX, US

Ticker Symbols

NASDAQ:BPTH

PHARMACEUTICAL PREPARATIONS
Business Address
4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
Mailing Address
4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
State Location
TX
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
P-ethoxy nucleic acids for liposomal formulation
- Patent number 12,097,214
- Issue date Sep 24, 2024
- BIO-PATH HOLDINGS, INC.
- Peter Nielsen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination therapy with liposomal antisense oligonucleotides
- Patent number 12,012,601
- Issue date Jun 18, 2024
- BIO-PATH HOLDINGS, INC.
- Ana Tari Ashizawa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
P-ethoxy nucleic acids for STAT3 inhibition
- Patent number 11,041,153
- Issue date Jun 22, 2021
- BIO-PATH HOLDINGS, INC.
- Ana Tari Ashizawa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination therapy with liposomal antisense oligonucleotides
- Patent number 10,927,379
- Issue date Feb 23, 2021
- BIO-PATH HOLDINGS, INC.
- Ana Tari Ashizawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
P-ethoxy nucleic acids for liposomal formulation
- Patent number 10,898,506
- Issue date Jan 26, 2021
- BIO-PATH HOLDINGS, INC.
- Peter Nielsen
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
P-ethoxy nucleic acids for liposomal formulation
- Patent number 10,335,428
- Issue date Jul 2, 2019
- BIO-PATH HOLDINGS, INC.
- Peter Nielsen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
p-Ethoxy nucleic acids for liposomal formulation
- Patent number 9,744,187
- Issue date Aug 29, 2017
- BIO-PATH HOLDINGS, INC.
- Peter Nielsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION
- Publication number 20220133775
- Publication date May 5, 2022
- Bio-Path Holdings, Inc.
- Ana Ashizawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION
- Publication number 20220127608
- Publication date Apr 28, 2022
- Bio-Path Holdings, Inc.
- Ana Tari ASHIZAWA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION
- Publication number 20210361695
- Publication date Nov 25, 2021
- Bio-Path Holdings, Inc.
- Peter NIELSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES
- Publication number 20210261972
- Publication date Aug 26, 2021
- Bio-Path Holdings, Inc.
- Ana Tari ASHIZAWA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR BCL2 INHIBITION
- Publication number 20210123058
- Publication date Apr 29, 2021
- Bio-Path Holdings, Inc.
- Ana Tari ASHIZAWA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION
- Publication number 20210115451
- Publication date Apr 22, 2021
- Bio-Path Holdings, Inc.
- Ana Tari ASHIZAWA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION
- Publication number 20200113928
- Publication date Apr 16, 2020
- Bio-Path Holdings, Inc.
- Peter NIELSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION
- Publication number 20200038429
- Publication date Feb 6, 2020
- Bio-Path Holdings, Inc.
- Ana Ashizawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION
- Publication number 20200040339
- Publication date Feb 6, 2020
- Bio-Path Holdings, Inc.
- Ana Tari ASHIZAWA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES
- Publication number 20200032271
- Publication date Jan 30, 2020
- Bio-Path Holdings, Inc.
- Ana Tari ASHIZAWA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION
- Publication number 20180161360
- Publication date Jun 14, 2018
- Bio-Path Holdings, Inc.
- Peter NIELSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION
- Publication number 20170106010
- Publication date Apr 20, 2017
- Bio-Path Holdings, Inc.
- Peter NIELSEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Trademarklast 30 trademarks

Information Trademark
86619557 - DNABILIZE
- Serial number 86619557
- Registration number 5241980
- Filing date May 5, 2015
- Bio-Path Holdings, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86619563 - DNABILIZE
- Serial number 86619563
- Registration number 5046468
- Filing date May 5, 2015
- Bio-Path Holdings, Inc.
- 45 - Legal services
Information Trademark
86619562 - DNABILIZE
- Serial number 86619562
- Registration number 5281665
- Filing date May 5, 2015
- Bio-Path Holdings, Inc.
- 42 - Scientific and technological services and research and design relating thereto

Bio-Path Holdings, Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

P-ethoxy nucleic acids for liposomal formulation

Combination therapy with liposomal antisense oligonucleotides

P-ethoxy nucleic acids for STAT3 inhibition

Combination therapy with liposomal antisense oligonucleotides

P-ethoxy nucleic acids for liposomal formulation

P-ethoxy nucleic acids for liposomal formulation

p-Ethoxy nucleic acids for liposomal formulation

Patents Applicationslast 30 patents

P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION

P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION

COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES

P-ETHOXY NUCLEIC ACIDS FOR BCL2 INHIBITION

P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION

P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

P-ETHOXY NUCLEIC ACIDS FOR STAT3 INHIBITION

COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES

P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION

P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION

Trademarklast 30 trademarks

86619557 - DNABILIZE

86619563 - DNABILIZE

86619562 - DNABILIZE